SynthesisSurgical endoscopy2026
Prevalence and clinical characteristics of blown-out myotomy after E-POEM for achalasia: a systematic review and meta-analysis.
Synthesis in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- [Endoscopic Treatment of Esophageal Motility Disorders in the Era of POEM: Current Perspectives and Future Directions].The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAchalasia is a primary esophageal motility disorder characterized by impaired lower esophageal sphincter relaxation and absent peristalsis. Treatment options include Pneumatic Dilation, Laparoscopic Heller Myotomy, and Esophageal Peroral Endoscopic Myotomy (E-POEM). A focal distal esophageal dilation at the myotomy site, termed blown-out myotomy (BOM), has been reported in 9% - 32% of patients and may be associated with reflux, esophageal retention, and treatment failure. The clinical significance of BOM remains unclear. This meta-analysis evaluated the prevalence and clinical characteristics of BOM following E-POEM.
methodsA systematic search of electronic databases and conference proceedings from inception through November 2025 identified prospective and retrospective studies reporting the prevalence or clinical features of BOM after E-POEM. The primary outcome was pooled BOM prevalence. Secondary outcomes included symptom severity (Eckardt score), myotomy characteristics, and associations with achalasia subtypes. Studies reporting ≤ 3 BOM cases or lacking extractable data were excluded. Pooled proportions were calculated using a fixed-effects model. Publication bias was assessed using the Begg-Mazumdar test. Mean Eckardt scores were compared using an unpaired t-test.
resultsFour studies comprising 947 patients were included. The pooled prevalence of BOM was 11.16% (95% CI: 9.28% -13.25%). No evidence of publication bias was detected (Kendall's tau-b = 0.33; p = 0.75). Baseline characteristics were comparable between groups. Mean myotomy length was 10.39 ± 1.82 cm in the BOM group and 11.23 ± 1.46 cm in the non-BOM group. Pretreatment Eckardt scores were similar (6.67 vs 6.63), as were 3-month post-E-POEM scores (2.05 vs 1.93). Pooled odds ratios for BOM were 0.73 (95% CI: 0.47-1.13) for type I achalasia, 0.79 (95% CI: 0.53-1.19) for type II, and 1.38 (95% CI: 0.80-2.38) for type III.
conclusionsBOM occurs in a minority of patients following E-POEM. Across studies, BOM did not show consistent associations with symptoms or procedural characteristics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.